Booster vaccination protection against SARS-CoV-2 infections in young adults during an Omicron BA.1-predominant period: A retrospective cohort study
Abstract
While booster vaccinations clearly reduce the risk of severe Coronavirus Disease 2019 (COVID-19) and death, the impact of boosters on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infections has not been fully characterized: Doing so requires understanding their impact on asymptomatic and mildly symptomatic infections that often go unreported but nevertheless play an important role in spreading SARS-CoV-2. We sought to estimate the impact of COVID-19 booster doses on SARS-CoV-2 infections in a vaccinated population of young adults during an Omicron BA.1-predominant period.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Jan 10, 2023
- Source ID
- 10.1371/journal.pmed.1004153
Entities
People
- Casey L Cazer
- David Shmoys
- Genevive Meredith
- Jiayue Wan
- Marin E. Clarkberg
- Marwan Osman
- Peter Frazier
- Scarlett E. Lee
- Shane Henderson
Organizations
- Air Force Office of Scientific Research
- David and Lucile Packard Foundation
- Division of Civil, Mechanical & Manufacturing Innovation
- Division of Computing and Communication Foundations
- National Science Foundation